Press Releases Brain+ A/S

Equities

BRAINP

DK0061670205

Market Closed - Nasdaq Copenhagen Other stock markets 10:17:51 2024-05-08 am EDT			5-day change	1st Jan Change
0.093 ^DKK	-11.85%		-22.18%	-52.06%

May. 07	Brain+ Plans DKK9 Million Rights Issue to Help Fund Operations	MT
May. 07	Brain+ A/S Provides Earnings Guidance for the Year 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Brain+ A/S convenes the Annual General Meeting	May. 07	AQ
Brain+ publishes its Annual Report for 2023 - A year of market access, product development and a refocused commercial strategy	May. 07	AQ
Brain+ A/S announce a partially secured rights issue of units of approximately DKK 8.94 million to fund operations and execution of its UK commercialization plan	May. 07	AQ
Brain+ updates on implementation and scaling activities for its CST-Assistant in Denmark	May. 02	AQ
Brain+' CST-Assistant cited in leading Nordic Life Science magazine as an impactful health tech intervention for managing dementia	Apr. 30	AQ
Brain+ releases preliminary annual financial statements for 2023	Apr. 30	AQ
Brain+ announces a change in its Financial Calendar for 2024	Apr. 29	AQ
Successful educational CST course held with Malteser Germany based on the CST-Assistant	Apr. 26	AQ
Brain+ announces registration of directed issue with the Danish Business Authority	Apr. 11	AQ
Brain+ announces registration of series TO 3 warrant exercise with the Danish Business Authority	Apr. 10	AQ
Brain+ announces the outcome of its series TO 3 warrant exercise and decision to carry out a directed share issue to cover guarantor commitments	Mar. 26	AQ
Brain+ A/S specifies how to get TO 3 warrant compensation	Mar. 26	AQ
Brain+ A/S announces last day of trading in its warrants of series TO 3	Mar. 20	AQ
Brain+ starts UK Pilot Project on CST-Therapist Companion in partnership with Age UK	Mar. 19	AQ
Brain+ strategy update: Focus on the UK to reach proof-of-business and commercial scaling in 2024-2025	Mar. 18	AQ
Brain+ announces that 77% of its warrants of series TO 3 are now covered by commitments	Mar. 15	AQ
Brain+ announces that 58% of its warrants of series TO 3 are covered by early commitments	Mar. 11	AQ
Brain+ A/S announces amended terms for upcoming TO 3 warrant exercise	Mar. 07	AQ
Brain+ nominates an international digital health industry expert and experienced investor profile as new chairman candidate	Feb. 12	AQ
Brain+ partners with Quiddity Health, the #1 UK digital healthcare market specialist, to prepare UK market entry for CST-Therapist Companion	Feb. 09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Brain+ A/S

Equities

BRAINP

DK0061670205

Press Releases

Filters